The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Normal Bovine Calf Serum Market Research Report 2024
Synopsis
Bovine Calf Serum (BCS) is collected from calves that are less than 12 months old. The serum contains approximately double the protein of fetal bovine serum (FBS). BCS will promote growth in a variety of mammalian cell lines and is often used as a cost-effective substitute for FBS.
Global Normal Bovine Calf Serum market is projected to reach US$ 855.6 million in 2029, increasing from US$ 670 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Normal Bovine Calf Serum market research.
The bovine calf serum market is primarily driven by the increasing demand from various industries, including biotechnology, pharmaceuticals, and research laboratories. Bovine calf serum is a vital component in cell culture media, supporting cell growth and promoting cell proliferation in these industries' applications. The rising adoption of cell culture techniques in drug development, vaccine production, and other biotechnological processes has significantly contributed to the market's growth. Additionally, the surging demand for regenerative medicine and stem cell research further fuels the need for bovine calf serum. However, the market faces challenges related to ethical concerns over animal-derived products and the risk of transmitting infectious agents. Stringent regulations and efforts towards developing serum-free alternatives also pose obstacles to the market's expansion. To sustain growth, the industry must address these challenges and invest in research for safe and ethical alternatives while meeting the increasing demand for bovine calf serum.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Normal Bovine Calf Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Merck
Corning
Cytiva
Biowest
Bovogen
Moregate Biotech
Gemini
Sartorius (Bioind)
Animal Technologies
Tissue Culture Biologicals
Internegocios
Minhai Bio
Xinuo Bio
Wuhan Sanli
Segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Segment by Application
Scientific Research
Industrial Production
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Normal Bovine Calf Serum report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Bovine Calf Serum (BCS) is collected from calves that are less than 12 months old. The serum contains approximately double the protein of fetal bovine serum (FBS). BCS will promote growth in a variety of mammalian cell lines and is often used as a cost-effective substitute for FBS.
Global Normal Bovine Calf Serum market is projected to reach US$ 855.6 million in 2029, increasing from US$ 670 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Normal Bovine Calf Serum market research.
The bovine calf serum market is primarily driven by the increasing demand from various industries, including biotechnology, pharmaceuticals, and research laboratories. Bovine calf serum is a vital component in cell culture media, supporting cell growth and promoting cell proliferation in these industries' applications. The rising adoption of cell culture techniques in drug development, vaccine production, and other biotechnological processes has significantly contributed to the market's growth. Additionally, the surging demand for regenerative medicine and stem cell research further fuels the need for bovine calf serum. However, the market faces challenges related to ethical concerns over animal-derived products and the risk of transmitting infectious agents. Stringent regulations and efforts towards developing serum-free alternatives also pose obstacles to the market's expansion. To sustain growth, the industry must address these challenges and invest in research for safe and ethical alternatives while meeting the increasing demand for bovine calf serum.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Normal Bovine Calf Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Merck
Corning
Cytiva
Biowest
Bovogen
Moregate Biotech
Gemini
Sartorius (Bioind)
Animal Technologies
Tissue Culture Biologicals
Internegocios
Minhai Bio
Xinuo Bio
Wuhan Sanli
Segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Segment by Application
Scientific Research
Industrial Production
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Normal Bovine Calf Serum report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Normal Bovine Calf Serum Market Overview
1.1 Product Overview and Scope of Normal Bovine Calf Serum
1.2 Normal Bovine Calf Serum Segment by Type
1.2.1 Global Normal Bovine Calf Serum Market Value Comparison by Type (2023-2029)
1.2.2 USA-sourced
1.2.3 South America-sourced
1.2.4 Australia-sourced
1.2.5 Others
1.3 Normal Bovine Calf Serum Segment by Application
1.3.1 Global Normal Bovine Calf Serum Market Value by Application: (2023-2029)
1.3.2 Scientific Research
1.3.3 Industrial Production
1.4 Global Normal Bovine Calf Serum Market Size Estimates and Forecasts
1.4.1 Global Normal Bovine Calf Serum Revenue 2018-2029
1.4.2 Global Normal Bovine Calf Serum Sales 2018-2029
1.4.3 Global Normal Bovine Calf Serum Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Normal Bovine Calf Serum Market Competition by Manufacturers
2.1 Global Normal Bovine Calf Serum Sales Market Share by Manufacturers (2018-2023)
2.2 Global Normal Bovine Calf Serum Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Normal Bovine Calf Serum Average Price by Manufacturers (2018-2023)
2.4 Global Normal Bovine Calf Serum Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Normal Bovine Calf Serum, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Normal Bovine Calf Serum, Product Type & Application
2.7 Normal Bovine Calf Serum Market Competitive Situation and Trends
2.7.1 Normal Bovine Calf Serum Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Normal Bovine Calf Serum Players Market Share by Revenue
2.7.3 Global Normal Bovine Calf Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Normal Bovine Calf Serum Retrospective Market Scenario by Region
3.1 Global Normal Bovine Calf Serum Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Normal Bovine Calf Serum Global Normal Bovine Calf Serum Sales by Region: 2018-2029
3.2.1 Global Normal Bovine Calf Serum Sales by Region: 2018-2023
3.2.2 Global Normal Bovine Calf Serum Sales by Region: 2024-2029
3.3 Global Normal Bovine Calf Serum Global Normal Bovine Calf Serum Revenue by Region: 2018-2029
3.3.1 Global Normal Bovine Calf Serum Revenue by Region: 2018-2023
3.3.2 Global Normal Bovine Calf Serum Revenue by Region: 2024-2029
3.4 North America Normal Bovine Calf Serum Market Facts & Figures by Country
3.4.1 North America Normal Bovine Calf Serum Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Normal Bovine Calf Serum Sales by Country (2018-2029)
3.4.3 North America Normal Bovine Calf Serum Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Normal Bovine Calf Serum Market Facts & Figures by Country
3.5.1 Europe Normal Bovine Calf Serum Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Normal Bovine Calf Serum Sales by Country (2018-2029)
3.5.3 Europe Normal Bovine Calf Serum Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Normal Bovine Calf Serum Market Facts & Figures by Country
3.6.1 Asia Pacific Normal Bovine Calf Serum Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Normal Bovine Calf Serum Sales by Country (2018-2029)
3.6.3 Asia Pacific Normal Bovine Calf Serum Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Normal Bovine Calf Serum Market Facts & Figures by Country
3.7.1 Latin America Normal Bovine Calf Serum Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Normal Bovine Calf Serum Sales by Country (2018-2029)
3.7.3 Latin America Normal Bovine Calf Serum Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Normal Bovine Calf Serum Market Facts & Figures by Country
3.8.1 Middle East and Africa Normal Bovine Calf Serum Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Normal Bovine Calf Serum Sales by Country (2018-2029)
3.8.3 Middle East and Africa Normal Bovine Calf Serum Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Normal Bovine Calf Serum Sales by Type (2018-2029)
4.1.1 Global Normal Bovine Calf Serum Sales by Type (2018-2023)
4.1.2 Global Normal Bovine Calf Serum Sales by Type (2024-2029)
4.1.3 Global Normal Bovine Calf Serum Sales Market Share by Type (2018-2029)
4.2 Global Normal Bovine Calf Serum Revenue by Type (2018-2029)
4.2.1 Global Normal Bovine Calf Serum Revenue by Type (2018-2023)
4.2.2 Global Normal Bovine Calf Serum Revenue by Type (2024-2029)
4.2.3 Global Normal Bovine Calf Serum Revenue Market Share by Type (2018-2029)
4.3 Global Normal Bovine Calf Serum Price by Type (2018-2029)
5 Segment by Application
5.1 Global Normal Bovine Calf Serum Sales by Application (2018-2029)
5.1.1 Global Normal Bovine Calf Serum Sales by Application (2018-2023)
5.1.2 Global Normal Bovine Calf Serum Sales by Application (2024-2029)
5.1.3 Global Normal Bovine Calf Serum Sales Market Share by Application (2018-2029)
5.2 Global Normal Bovine Calf Serum Revenue by Application (2018-2029)
5.2.1 Global Normal Bovine Calf Serum Revenue by Application (2018-2023)
5.2.2 Global Normal Bovine Calf Serum Revenue by Application (2024-2029)
5.2.3 Global Normal Bovine Calf Serum Revenue Market Share by Application (2018-2029)
5.3 Global Normal Bovine Calf Serum Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Normal Bovine Calf Serum Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Normal Bovine Calf Serum Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Corning
6.3.1 Corning Corporation Information
6.3.2 Corning Description and Business Overview
6.3.3 Corning Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Corning Normal Bovine Calf Serum Product Portfolio
6.3.5 Corning Recent Developments/Updates
6.4 Cytiva
6.4.1 Cytiva Corporation Information
6.4.2 Cytiva Description and Business Overview
6.4.3 Cytiva Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cytiva Normal Bovine Calf Serum Product Portfolio
6.4.5 Cytiva Recent Developments/Updates
6.5 Biowest
6.5.1 Biowest Corporation Information
6.5.2 Biowest Description and Business Overview
6.5.3 Biowest Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Biowest Normal Bovine Calf Serum Product Portfolio
6.5.5 Biowest Recent Developments/Updates
6.6 Bovogen
6.6.1 Bovogen Corporation Information
6.6.2 Bovogen Description and Business Overview
6.6.3 Bovogen Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bovogen Normal Bovine Calf Serum Product Portfolio
6.6.5 Bovogen Recent Developments/Updates
6.7 Moregate Biotech
6.6.1 Moregate Biotech Corporation Information
6.6.2 Moregate Biotech Description and Business Overview
6.6.3 Moregate Biotech Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Moregate Biotech Normal Bovine Calf Serum Product Portfolio
6.7.5 Moregate Biotech Recent Developments/Updates
6.8 Gemini
6.8.1 Gemini Corporation Information
6.8.2 Gemini Description and Business Overview
6.8.3 Gemini Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Gemini Normal Bovine Calf Serum Product Portfolio
6.8.5 Gemini Recent Developments/Updates
6.9 Sartorius (Bioind)
6.9.1 Sartorius (Bioind) Corporation Information
6.9.2 Sartorius (Bioind) Description and Business Overview
6.9.3 Sartorius (Bioind) Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sartorius (Bioind) Normal Bovine Calf Serum Product Portfolio
6.9.5 Sartorius (Bioind) Recent Developments/Updates
6.10 Animal Technologies
6.10.1 Animal Technologies Corporation Information
6.10.2 Animal Technologies Description and Business Overview
6.10.3 Animal Technologies Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Animal Technologies Normal Bovine Calf Serum Product Portfolio
6.10.5 Animal Technologies Recent Developments/Updates
6.11 Tissue Culture Biologicals
6.11.1 Tissue Culture Biologicals Corporation Information
6.11.2 Tissue Culture Biologicals Normal Bovine Calf Serum Description and Business Overview
6.11.3 Tissue Culture Biologicals Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Tissue Culture Biologicals Normal Bovine Calf Serum Product Portfolio
6.11.5 Tissue Culture Biologicals Recent Developments/Updates
6.12 Internegocios
6.12.1 Internegocios Corporation Information
6.12.2 Internegocios Normal Bovine Calf Serum Description and Business Overview
6.12.3 Internegocios Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Internegocios Normal Bovine Calf Serum Product Portfolio
6.12.5 Internegocios Recent Developments/Updates
6.13 Minhai Bio
6.13.1 Minhai Bio Corporation Information
6.13.2 Minhai Bio Normal Bovine Calf Serum Description and Business Overview
6.13.3 Minhai Bio Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Minhai Bio Normal Bovine Calf Serum Product Portfolio
6.13.5 Minhai Bio Recent Developments/Updates
6.14 Xinuo Bio
6.14.1 Xinuo Bio Corporation Information
6.14.2 Xinuo Bio Normal Bovine Calf Serum Description and Business Overview
6.14.3 Xinuo Bio Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Xinuo Bio Normal Bovine Calf Serum Product Portfolio
6.14.5 Xinuo Bio Recent Developments/Updates
6.15 Wuhan Sanli
6.15.1 Wuhan Sanli Corporation Information
6.15.2 Wuhan Sanli Normal Bovine Calf Serum Description and Business Overview
6.15.3 Wuhan Sanli Normal Bovine Calf Serum Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Wuhan Sanli Normal Bovine Calf Serum Product Portfolio
6.15.5 Wuhan Sanli Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Normal Bovine Calf Serum Industry Chain Analysis
7.2 Normal Bovine Calf Serum Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Normal Bovine Calf Serum Production Mode & Process
7.4 Normal Bovine Calf Serum Sales and Marketing
7.4.1 Normal Bovine Calf Serum Sales Channels
7.4.2 Normal Bovine Calf Serum Distributors
7.5 Normal Bovine Calf Serum Customers
8 Normal Bovine Calf Serum Market Dynamics
8.1 Normal Bovine Calf Serum Industry Trends
8.2 Normal Bovine Calf Serum Market Drivers
8.3 Normal Bovine Calf Serum Market Challenges
8.4 Normal Bovine Calf Serum Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
